SHIONOGI & CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7,040 JPY | +0.92% |
|
+1.72% | +3.56% |
| May. 14 | Japan's Nikkei drifts sideways as more earnings, US CPI awaited | RE |
| May. 13 | Japan's Shionogi says COVID treatment did not meet endpoint in late-stage trial | RE |
| Sales 2024 | 435B 2.76B | Sales 2025 * | 432B 2.74B | Capitalization | 1,996B 12.68B |
|---|---|---|---|---|---|
| Net income 2024 | 162B 1.03B | Net income 2025 * | 154B 977M | EV / Sales 2024 | 5.05 x |
| Net cash position 2024 * | 473B 3.01B | Net cash position 2025 * | 542B 3.45B | EV / Sales 2025 * | 3.37 x |
| P/E ratio 2024 |
13.9
x | P/E ratio 2025 * |
13
x | Employees | 4,959 |
| Yield 2024 |
2.06% | Yield 2025 * |
2.36% | Free-Float | 87.27% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
| 1 day | +0.92% | ||
| 1 week | +1.72% | ||
| 1 month | -4.53% | ||
| 3 months | -5.93% | ||
| 6 months | +0.89% | ||
| Current year | +3.56% |
1 week
6 867.00
7 134.00
1 month
6 729.007 650.00
Current year
6 729.008 137.00
1 year
5 718.008 137.00
3 years
5 438.008 439.00
5 years
4 379.008 439.00
10 years
2 019.008 439.00
| Managers | Title | Age | Since |
|---|---|---|---|
Isao Teshirogi
CEO | Chief Executive Officer | 64 | 82-03-31 |
Yuji Hosogai
DFI | Director of Finance/CFO | - | - |
Yasuetsu Imune
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hiroshi Ozaki
BRD | Director/Board Member | 74 | 19-05-31 |
Isao Teshirogi
CEO | Chief Executive Officer | 64 | 82-03-31 |
Takuko Sawada
BRD | Director/Board Member | 69 | 77-03-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 4.69% | 19 M€ | +11.22% | ||
| 2.51% | 7 M€ | +9.96% | - | |
| 1.07% | 57 M€ | +19.30% | ||
| 1.05% | 10 M€ | +15.87% | - | |
| 1.04% | 240 M€ | +17.47% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 7,040 | +0.92% | 4,631,200 |
| 24-05-30 | 6,976 | -0.20% | 1,636,400 |
| 24-05-29 | 6,990 | -0.10% | 888,500 |
| 24-05-28 | 6,997 | +1.10% | 798,900 |
| 24-05-27 | 6,921 | -.--% | 731,700 |
Delayed Quote Japan Exchange, May 31, 2024 at 02:00 am EDT
More quotes
Shionogi & Co., Ltd. specializes in development, manufacturing and marketing of pharmaceutical products. The group's activity is organized around 3 families of products:
- prescription products: drugs for the treatment of cardiovascular and infectious diseases, diabetes, allergic reactions, etc.;
- OTC products: analgesic products, vitamins and tonics, etc.;
- diagnosis products: primarily for detection and treatment of cardiovascular diseases and immune system.
Sector
Pharmaceuticals
Calendar
2024-06-06
- R&D Day
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
7,040
JPY
Average target price
7,967
JPY
Spread / Average Target
+13.17%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +3.56% | 12.69B | |
| +40.73% | 739B | |
| +32.83% | 598B | |
| -6.30% | 353B | |
| +15.15% | 318B | |
| +4.05% | 285B | |
| +15.00% | 240B | |
| +9.78% | 210B | |
| -5.52% | 206B | |
| +6.17% | 164B |
- Stock Market
- Equities
- 4507 Stock
